Advertisement

Treatment of hypertension in the elderly

  • Ray W. GiffordJr.
  • Raymond A. Borazanian
Part of the Developments in Nephrology book series (DINE, volume 34)

Abstract

By virtue of sheer numbers, hypertension in the elderly is a major public health problem: prevalence of hypertension is high in this age group, and the elderly segment of the American population is growing rapidly. The confirmed benefit of treatment of hypertension in the elderly, both isolated systolic and diastolic, makes it even more important now than ever to identify and treat such patients.

Keywords

Diastolic Blood Pressure Systolic Hypertension Sick Sinus Syndrome Diastolic Hypertension Hypertension Detection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Vokonas PS, Kannel WB, Cupples LA. Epidemiology and risk of hypertension in the elderly: the Framingham Study. J Hypertens 1988; 6(Suppl 1):S3–S9.Google Scholar
  2. 2.
    Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension prevalence and the status of awareness, treatment, and control in the United States. Final report. Hypertension 1985; 7:457–468.Google Scholar
  3. 3.
    Curb JD, Borhani BO, Schnaper H, Kass E, Entwisle G, Williams W, Berman R. Detection and treatment of hypertension in older individuals. Am J Epidemiol 1985; 121:371–376.CrossRefPubMedGoogle Scholar
  4. 4.
    Adamopoulos PN, Chrysanthakapoulis SG, Frohlich ED. Systolic hypertension: Nonhomogeneous diseases. Am J Cardiol 1975; 36:697–701.CrossRefPubMedGoogle Scholar
  5. 5.
    Garland C, Barrett-Connor E, Suarez L, Criqui MH. Isolated systolic hypertension and mortality after age 60 years. A prospective population-based study. Am J Epidemiol 1983; 118:365–376.PubMedGoogle Scholar
  6. 6.
    Rutan GH, Kuller LH, Neaton DJ, Wentworth DN, McDonald RH, Smith WM. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988; 77:504–514.CrossRefPubMedGoogle Scholar
  7. 7.
    Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race, sex and age. JAMA 1979; 242:2572–2577.CrossRefGoogle Scholar
  8. 8.
    Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. III. Reduction in stroke incidence among persons with high blood pressure. JAMA 1982; 247:633–638.CrossRefGoogle Scholar
  9. 9.
    Borhani NO. Results of clinical trials regarding the efficacy of treating hypertension. Clin Geriatric Med 1989; 5:675–690.Google Scholar
  10. 10.
    National Heart Foundation of Australia. Treatment of mild hypertension in the elderly. Med J Aust 1981; 2:398–402.Google Scholar
  11. 11.
    Amery A, Brixko P, Clement D, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985; 1:1349–1354.CrossRefPubMedGoogle Scholar
  12. 12.
    Amery A, Brixko R, Clement D, et al: Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 1986; 2:589–592.CrossRefPubMedGoogle Scholar
  13. 13.
    Fletcher A, Amery A, Birkenhager W, Bulpitt C, et al. Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly. J Hypertens 1991; 9:225–230.CrossRefPubMedGoogle Scholar
  14. 14.
    Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338:1281–1285.CrossRefPubMedGoogle Scholar
  15. 15.
    SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255–3264.CrossRefGoogle Scholar
  16. 16.
    MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304:405–412.CrossRefGoogle Scholar
  17. 17.
    Beard K, Bulpitt C, Mascie-Taylor H, O’Malley K, Sever P, Webb S. Management of elderly patients with sustained hypertension. Br Med J 1992; 304:412–416.CrossRefGoogle Scholar
  18. 18.
    Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA 1991; 265:489–495.CrossRefPubMedGoogle Scholar
  19. 19.
    Heikenheimo RJ, Haavisto MV, Kaarela RH, Kanto AJ, Koivunen MJ, Rajala SA. Blood pressure in the very old. J Hypertens 1990; 8:361–367.CrossRefGoogle Scholar
  20. 20.
    Staesson J, Bulpitt C, Clement D, DeLeeuw P, Fagard R, Fletcher A, Forette F, Leonetti G, Nissinen A, O’Malley K, Tuomilehto J, Webseter J, Williams BO. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working party on High Blood Pressure in the Elderly. Br Med J 1989; 298:1552–1556.CrossRefGoogle Scholar
  21. 21.
    Coope J, Warrender TS: Randomised trial of treatment in elderly patients in primary care. B M J 1986; 293:1145–1151.CrossRefGoogle Scholar
  22. 22.
    Coope J, Warrender TS. Lowering blood pressure (letter). Lancet 1987; 2:1380.CrossRefGoogle Scholar
  23. 23.
    Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150:841–845.CrossRefPubMedGoogle Scholar
  24. 24.
    Curb JD, Borhani NO, Blaszowski T, Fotiu S, Zimbaldi N, on behalf of the HDFP Cooperative Group. Adverse reactions to antihypertensive drugs in the Hypertension Detection and Follow-up Program (HDFP). Circulation 1982; 66:II-328.Google Scholar
  25. 25.
    Materson BJ, Cushman WC, Goldstein G, Reda DJ, Freis ED, Ramirez EA, Talmers FN, White TJ, Nunn S, Chapman RH, Khatri I, Schnaper H, Thomas JR, Henderson WG, Fye C. Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs cooperative study. Hypertension 1990; 15:348–360.CrossRefPubMedGoogle Scholar
  26. 26.
    Goldstein G, Materson BJ, Cushman WC, Reda DJ, Freis ED, Ramirez EA, Talmers FN, White TJ, Nunn S, Chapman RH, Khatri I, Schnaper H, Thomas JR, Henderson WG, Fye C. Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension 1990; 15:361–369.CrossRefPubMedGoogle Scholar
  27. 27.
    Applegate WB, Phillips HL, Schnaper H, Shepherd AMM, Schocken D, Luhr JC, Koch GG, Park GD. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 1991; 151:1817–1823.CrossRefPubMedGoogle Scholar
  28. 28.
    Gurland BJ, Teresi J, Smith WM, Black D, Hughes G, Edlavitch S. Effects of treatment for isolated systolic hypertension on cognitive status and depression in the elderly. J Am Geriatr Soc 1988; 36:1015–1022.PubMedGoogle Scholar
  29. 29.
    Cushman WC, Khatri I, Materson BJ, Reda DJ, Freis ED, Goldstein G, Ramirez EA, Talmers FN, White TJ, Nunn S, Schnaper H, Thomas JR, Henderson WG, Fye C. Treatment of hypertension in the elderly. III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: Results of a Department of Veterans Affairs cooperative study. Arch Intern Med 1991; 151:1954–1960.CrossRefPubMedGoogle Scholar
  30. 30.
    Jeunmaitre X, Charru A, Chatellier G, Degoulet P, et al. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension. Am J Cardiol 1988; 62:1072–1077.CrossRefGoogle Scholar
  31. 31.
    Working Group on Hypertension in the Elderly. Statement on hypertension in the elderly. JAMA 1986; 256:70.CrossRefGoogle Scholar
  32. 32.
    Bühler FR, Bolli P, Kiowski W, Erne P, Hulthen UL, Block LH. Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients. Am J Med 1984; 77(2A):36–42.PubMedGoogle Scholar
  33. 33.
    Blaufox MD, Lee HB, Davis B, Oberman A, Wassertheil-Smoller S, Langford H. Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy. JAMA 1992; 267:1221–1225.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1993

Authors and Affiliations

  • Ray W. GiffordJr.
  • Raymond A. Borazanian

There are no affiliations available

Personalised recommendations